Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus

Suzanne D Vernon, Toni Whistler, Barbara Cameron, Ian B Hickie, William C Reeves, Andrew Lloyd, Suzanne D Vernon, Toni Whistler, Barbara Cameron, Ian B Hickie, William C Reeves, Andrew Lloyd

Abstract

Background: Acute infectious diseases are typically accompanied by non-specific symptoms including fever, malaise, irritability and somnolence that usually resolve on recovery. However, in some individuals these symptoms persist in what is commonly termed post-infective fatigue. The objective of this pilot study was to determine the gene expression correlates of post-infective fatigue following acute Epstein Barr virus (EBV) infection.

Methods: We followed 5 people with acute mononucleosis who developed post-infective fatigue of more than 6 months duration and 5 HLA-matched control subjects who recovered within 3 months. Subjects had peripheral blood mononuclear cell (PBMC) samples collected at varying time points including at diagnosis, then every 2 weeks for 3 months, then every 3 months for a year. Total RNA was extracted from the PBMC samples and hybridized to microarrays spotted with 3,800 oligonucleotides.

Results: Those who developed post-infective fatigue had gene expression profiles indicative of an altered host response during acute mononucleosis compared to those who recovered uneventfully. Several genes including ISG20 (interferon stimulated gene), DNAJB2 (DnaJ [Hsp40] homolog and CD99), CDK8 (cyclin-dependent kinase 8), E2F2 (E2F transcription factor 2), CDK8 (cyclin-dependent kinase 8), and ACTN2 (actinin, alpha 2), known to be regulated during EBV infection, were differentially expressed in post-infective fatigue cases. Several of the differentially expressed genes affect mitochondrial functions including fatty acid metabolism and the cell cycle.

Conclusion: These preliminary data provide insights into alterations in gene transcripts associated with the varied clinical outcomes from acute infectious mononucleosis.

Figures

Figure 1
Figure 1
There were 23 of 636 genes that were expressed at different levels between cases (blue bars) and controls (orange bars) at the early time point. The majority of these (15/23) were expressed at higher levels in the cases compared to controls and most were involved in cell cycle and metabolism. The four genes known to be involved in translation, were expressed at much lower levels in the cases compared to controls.
Figure 2
Figure 2
Comparison of genes that were expressed at similar levels during early and late time points for cases (blue bars) but were different for controls (orange bars). There were 24 of 636 genes that were differentially expressed. Half of these genes have known mitochondrial function and are marked with an asterisk.
Figure 3
Figure 3
Cluster analysis of 24 differentially expressed genes of all samples from cases and controls at both early and late time points. The samples separated into 2 major groups; one containing most of the case samples and the other containing both cases and controls. The genes also grouped into 2 major groups; one that contained most of the mitochondrial function genes that were upregulated in cases and the other contained cell cycle checkpoints and DNA replication genes that were down regulated in the case group.

References

    1. Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12:123–137. doi: 10.1016/S0149-7634(88)80004-6.
    1. Dantzer R, Bluthe R-M, Aubert A, Goodall G, Bret-Dibat J-L, Kent S, Goujon E, Laye S, Parnet P, Kelley KW. Cytokine actions on behavior. In: Rothwell NJ, editor. Cytokines in the nervous system. RG Landes Co.; 1996.
    1. Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002;25:154–159. doi: 10.1016/S0166-2236(00)02088-9.
    1. Hickie IB, Bansal A, Kirk KM, Lloyd AR, Martin NG. A twin study of the etiology of prolonged fatigue and immune activation. Twin Research. 2001;4:94–102. doi: 10.1375/1369052012209.
    1. Maier SF. Bi-directional Immune-brain communication: Implications for understanding stress, pain and cognition. Brain Behav Immun. 2003;17:69–85. doi: 10.1016/S0889-1591(03)00032-1.
    1. Smith A, Thomas M, Kent J, Nicholson K. Effects of the common cold on mood and performance. Psychoneuroendocrinology. 1998;23:733–739. doi: 10.1016/S0306-4530(98)00042-0.
    1. Capuron L, Lamarque D, Dantzer R, Goodall G. Attentional and mnemonic deficits associated with infective disease in humans. Psychol Med. 1999;29:291–297. doi: 10.1017/S0033291798007740.
    1. Vollmer-Conna U, Bird K, Lemon J, Lloyd A, Wakefield D. Cognitive performance, mood and immune function in patients with chronic fatigue syndrome, acute viral illness, major depression and healthy control subjects. Br J Psych. 1997;171:377–381.
    1. Isaacs R. Chronic infective mononucleosis. Blood. 1948;3:858–861.
    1. Buchwald DS, Rea T, Katon W, Russo J, Ashley RL. Acute infective mononucleosis: characteristics of patients who report failure to recover. Am J Med. 2000;109:531–537. doi: 10.1016/S0002-9343(00)00560-X.
    1. White PD, Thomas JM, Kangro HO, Bruce-Jones WDA, Amess J, Crawford DH, Grover SA, Cleare AW. Predictions and associations of fatigue syndromes and mood disorders that occur after infective mononucleosis. Lancet. 2001;358:1946–1954. doi: 10.1016/S0140-6736(01)06961-6.
    1. Robertson P, Beynon S, Whybin R, Brennan C, Volmer-Conna U, Hickie I, Lloyd A. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. J Med Virol. 2003;70:617–623. doi: 10.1002/jmv.10439.
    1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953–959.
    1. Ojaniemi H, Evengard B, Lee DR, Unger ER, Vernon SD. Impact of RNA extraction from limited samples on microarray results. Biotechniques. 2003;35:968–73.
    1. Whistler T, Unger ER, Nisenbaum R, Vernon SD. Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome. J Transl Med. 2003;1:10. doi: 10.1186/1479-5876-1-10.
    1. Cheadle C, Cho-Chung YS, Becker KG, Vawter MP. Application of z-score transformation to Affymetrix data. Appl Bioinformatics. 2003;2:209–217.
    1. Dennis G, Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3. doi: 10.1186/gb-2003-4-5-p3.
    1. Hosack DA, Dennis G, Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003;4:R70. doi: 10.1186/gb-2003-4-10-r70.
    1. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863–14868. doi: 10.1073/pnas.95.25.14863.
    1. Joshi-Tope G, Gillespie M, Vastrik I, D'Eustachio P, Schmidt E, de Bono B, Jassal B, Gopinath GR, Wu GR, Matthews L, Lewis S, Birney E, Stein L. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 2005;1:D428–32.
    1. Buchwald DS, Rea TD, Katon WJ, Russo JE, Ashley RL. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am J Med. 2000;109:531–537. doi: 10.1016/S0002-9343(00)00560-X.
    1. White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO, Clare AW. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry. 1998;173:475–481.
    1. White PD, Thomas JM, Sullivan PF, Buchwald D. The nosology of sub-acute and chronic fatigue syndromes that follow infectious mononucleosis. Psychol Med. 2004;34:499–507. doi: 10.1017/S0033291703001302.
    1. Salek-Ardakani S, Lyons SA, Arrand JR. Epstein-Barr virus promotes human monocyte survival and maturation through a paracrine induction of IFN-alpha. J Immunol. 2004;173:321–331.
    1. Kudoh A, Fujita M, Kiyono T, Kuzushima K, Sugaya Y, Izuta S, Nishiyama Y, Tsurumi T. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J Virol. 2003;77:851–861. doi: 10.1128/JVI.77.2.851-861.2003.
    1. Labrousse AL, Buisson-Legendre N, Hornebeck W, Bernard P. The metalloprotease-directed shedding of BP 180 (collagen XVII) from human keratinocytes in culture is unaffected by ceramide and cell-matrix interaction. Eur J Dermatol. 2002;12:240–246.
    1. Lu J, Chua HH, Chen SY, Chen JY, Tsai CH. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. Cancer Res. 2003;63:256–262.
    1. Kim MA, Lee HS, Yang HK, Kim WH. Cytokeratin expression profile in gastric carcinomas. Hum Pathol. 2004;35:576–581. doi: 10.1016/j.humpath.2003.12.007.
    1. Dufva M, Olsson M, Rymo L. Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway. J Gen Virol. 2001;82:1581–1587.
    1. Li Y, Webster-Cyriaque J, Tomlinson CC, Yohe M, Kenney S. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. J Virol. 2004;78:4197–4206. doi: 10.1128/JVI.78.8.4197-4206.2004.
    1. Kawanishi M, Tada-Oikawa S, Kawanishi S. Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells. Biochem Biophys Res Commun. 2002;297:682–687. doi: 10.1016/S0006-291X(02)02261-1.
    1. Lu ZX, Ye M, Yan GR, Li Q, Tang M, Lee LM, Sun LQ, Cao Y. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis. Cancer Gene Ther. 2005;12:647–654. doi: 10.1038/sj.cgt.7700833.
    1. Cameron B, Bharadwaj M, Burrows J, Fazou C, Wakefield D, Hickie I, Ffrench R, Khanna R, Lloyd A. Prolonged illness following infective mononucleosis does not correlate with viral load but is associated with altered immune responses. J Infectious Diseases.
    1. Vojdani A, Ghoneum MB, Choppa PC, Magtoto L, Lapp CW. Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. J Intern Med. 1997;242:465–478.
    1. Kennedy G, Spence V, Underwood C, Belch JJ. Increased neutrophil apoptosis in chronic fatigue syndrome. J Clin Pathol. 2004;57:891–893. doi: 10.1136/jcp.2003.015511.

Source: PubMed

3
Abonneren